Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
Completed · Phase 2 · Has a placebo group
Conditions studied: Hepatobiliary Disorders, Non-alcoholic Steatohepatitis
In brief
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis
Key facts
- Study ID
- NCT02970942
- Run by
- Novo Nordisk A/S
- People needed
- 320
- Starts
- 2016-11-30
- Expected to finish
- 2020-03-19
- Last updated by the study team
- 2021-11-16
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — Chandler, Arizona, United States
- Novo Nordisk Investigational Site — Tucson, Arizona, United States
- Novo Nordisk Investigational Site — Coronado, California, United States
- Novo Nordisk Investigational Site — Costa Mesa, California, United States
- Novo Nordisk Investigational Site — La Mesa, California, United States
- Novo Nordisk Investigational Site — Los Angeles, California, United States
- Novo Nordisk Investigational Site — Northridge, California, United States
- Novo Nordisk Investigational Site — Panorama City, California, United States
- Novo Nordisk Investigational Site — Rialto, California, United States
- Novo Nordisk Investigational Site — Boca Raton, Florida, United States
- Novo Nordisk Investigational Site — Gainesville, Florida, United States
- Novo Nordisk Investigational Site — Jacksonville, Florida, United States
- Novo Nordisk Investigational Site — Lakewood Rch, Florida, United States
- Novo Nordisk Investigational Site — Miami, Florida, United States
- Novo Nordisk Investigational Site — Miami, Florida, United States
- Novo Nordisk Investigational Site — Ocoee, Florida, United States
- Novo Nordisk Investigational Site — Sarasota, Florida, United States
- Novo Nordisk Investigational Site — Monroe, Louisiana, United States
- Novo Nordisk Investigational Site — Baltimore, Maryland, United States
- Novo Nordisk Investigational Site — Detroit, Michigan, United States
- Novo Nordisk Investigational Site — Rochester, Minnesota, United States
- Novo Nordisk Investigational Site — Omaha, Nebraska, United States
- Novo Nordisk Investigational Site — Las Vegas, Nevada, United States
- Novo Nordisk Investigational Site — Las Vegas, Nevada, United States
- Novo Nordisk Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.